Skip to main content
Erschienen in: Acta Neurologica Belgica 2/2020

12.11.2018 | Original Article

Perception and attitude of the general population towards Alzheimer’s disease in Jeddah, Saudi Arabia

verfasst von: Hussein Algahtani, Bader Shirah, Asim Alhazmi, Abid Alshareef, Mohammed Bajunaid, Ahmad Samman

Erschienen in: Acta Neurologica Belgica | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

There are many conflicting beliefs about Alzheimer’s disease in the general population. Conducting a study on public awareness, attitude, and knowledge towards Alzheimer’s disease is useful in decreasing discrimination and stigmatization. This study aims to determine the public perception and attitude towards Alzheimer’s disease in Jeddah, Saudi Arabia. In addition, we aim to identify the religious and cultural beliefs about the causes and treatment of Alzheimer’s disease in Saudi Arabia. This is a cross-sectional study that was conducted in malls and public places in Jeddah, Saudi Arabia. The instrument used in this study was a self-administered questionnaire that consists of 40 items. A total of 32 questions were included into the survey, which was subdivided into four sources of information that include general information about Alzheimer’s disease, information about Alzheimer’s disease in the society, general information about persons with Alzheimer’s disease, and information about the care of persons with Alzheimer’s disease. In addition, eight questions were used to collect information about the demographic profile of the participants. A total of 1698 individuals participated in the study. 1511 participants (89%) had heard about Alzheimer’s disease before. Around 46% of the participants think that the cause of Alzheimer’s disease is a brain disease and 44.9% think that is a normal part of aging. Approximately, 30% of the participants believe that Alzheimer’s disease is treated with medications and 24.6% believe that there is no treatment. Around 30% of the participant think that the society treats persons with Alzheimer’s disease with stigmatization. More than half of the participants (56.2%) think that persons with Alzheimer’s disease should not be admitted to the nursing home. The results of the present study suggest that the perception of the general public of Alzheimer’s disease is lagging behind. Many wrong beliefs were identified in the general public regarding the causes and management. The findings of our study suggest that more information about Alzheimer’s disease would be valuable and beneficial for everyone. Awareness campaigns and public education are needed to increase the knowledge of the general public regarding several aspects of the disease including prevention, causes, and management. Dissemination of information about Alzheimer’s disease should be of high priority. Increased awareness will lead to earlier detection of Alzheimer’s disease and other dementia cases and appropriate care and management of those persons.
Literatur
1.
Zurück zum Zitat Huynh RA, Mohan C (2017) Alzheimer’s disease: biomarkers in the genome, blood, and cerebrospinal fluid. Front Neurol 8:102CrossRef Huynh RA, Mohan C (2017) Alzheimer’s disease: biomarkers in the genome, blood, and cerebrospinal fluid. Front Neurol 8:102CrossRef
2.
Zurück zum Zitat Haaksma ML, Vilela LR, Marengoni A et al (2017) Comorbidity and progression of late onset Alzheimer’s disease: a systematic review. PLoS One 12(5):e0177044CrossRef Haaksma ML, Vilela LR, Marengoni A et al (2017) Comorbidity and progression of late onset Alzheimer’s disease: a systematic review. PLoS One 12(5):e0177044CrossRef
3.
Zurück zum Zitat Richardson JR, German D, Levey A (2014) Alzheimer disease risk factors. JAMA Neurol 71(8):1051CrossRef Richardson JR, German D, Levey A (2014) Alzheimer disease risk factors. JAMA Neurol 71(8):1051CrossRef
4.
Zurück zum Zitat Rizzi L, Rosset I, Roriz-cruz M (2014) Global epidemiology of dementia: Alzheimer’s and vascular types. Biomed Res Int 2014:908915CrossRef Rizzi L, Rosset I, Roriz-cruz M (2014) Global epidemiology of dementia: Alzheimer’s and vascular types. Biomed Res Int 2014:908915CrossRef
5.
Zurück zum Zitat Abyad A (2015) Alzheimer’s in the middle east. JSM Alzheimer’s Dis Relat Dement 2(1):1012 Abyad A (2015) Alzheimer’s in the middle east. JSM Alzheimer’s Dis Relat Dement 2(1):1012
7.
Zurück zum Zitat Alkhunizan M, Alkhenizan A, Basudan L (2018) Prevalence of mild cognitive impairment and dementia in Saudi Arabia: a community-based study. Dement Geriatr Cogn Dis Extra 8(1):98–103CrossRef Alkhunizan M, Alkhenizan A, Basudan L (2018) Prevalence of mild cognitive impairment and dementia in Saudi Arabia: a community-based study. Dement Geriatr Cogn Dis Extra 8(1):98–103CrossRef
8.
Zurück zum Zitat Roberts JS, Connell CM, Cisewski D, Hipps YG, Demissie S, Green RC (2003) Differences between African Americans and whites in their perceptions of Alzheimer disease. Alzheimer Dis Assoc Disord 17(1):19–26CrossRef Roberts JS, Connell CM, Cisewski D, Hipps YG, Demissie S, Green RC (2003) Differences between African Americans and whites in their perceptions of Alzheimer disease. Alzheimer Dis Assoc Disord 17(1):19–26CrossRef
9.
Zurück zum Zitat Connell CM, Scott roberts J, Mclaughlin SJ (2007) Public opinion about Alzheimer disease among blacks, hispanics, and whites: results from a national survey. Alzheimer Dis Assoc Disord 21(3):232–240CrossRef Connell CM, Scott roberts J, Mclaughlin SJ (2007) Public opinion about Alzheimer disease among blacks, hispanics, and whites: results from a national survey. Alzheimer Dis Assoc Disord 21(3):232–240CrossRef
10.
Zurück zum Zitat Nielsen TR, Waldemar G (2016) Knowledge and perceptions of dementia and Alzheimer’s disease in four ethnic groups in Copenhagen, Denmark. Int J Geriatr Psychiatry 31(3):222–230CrossRef Nielsen TR, Waldemar G (2016) Knowledge and perceptions of dementia and Alzheimer’s disease in four ethnic groups in Copenhagen, Denmark. Int J Geriatr Psychiatry 31(3):222–230CrossRef
11.
Zurück zum Zitat Roberts JS, Mclaughlin SJ, Connell CM (2014) Public beliefs and knowledge about risk and protective factors for Alzheimer’s disease. Alzheimers Dement 10(5 Suppl):S381–S389CrossRef Roberts JS, Mclaughlin SJ, Connell CM (2014) Public beliefs and knowledge about risk and protective factors for Alzheimer’s disease. Alzheimers Dement 10(5 Suppl):S381–S389CrossRef
12.
Zurück zum Zitat Chen YG (2018) Research progress in the pathogenesis of Alzheimer’s disease. Chin Med J 131(13):1618–1624CrossRef Chen YG (2018) Research progress in the pathogenesis of Alzheimer’s disease. Chin Med J 131(13):1618–1624CrossRef
13.
Zurück zum Zitat Peterson R, Graff-Radford J (2016) Alzheimer disease and other dementias. In: Daroff RB, Jankovic J, Mazziotta JC, Pomeroy SL (eds) Bradley’s neurology in clinical practice, 7th edn. Elsevier, London, pp 1380–1421 Peterson R, Graff-Radford J (2016) Alzheimer disease and other dementias. In: Daroff RB, Jankovic J, Mazziotta JC, Pomeroy SL (eds) Bradley’s neurology in clinical practice, 7th edn. Elsevier, London, pp 1380–1421
14.
Zurück zum Zitat Kurlan R, Rabin ML. Pseudoparkinsonism (2013) A review of a common nonparkinsonian hypokinetic movement disorder. Adv Parkinson’s Dis 2(4):108–112CrossRef Kurlan R, Rabin ML. Pseudoparkinsonism (2013) A review of a common nonparkinsonian hypokinetic movement disorder. Adv Parkinson’s Dis 2(4):108–112CrossRef
15.
Zurück zum Zitat Cohen M, Werner P, Azaiza F (2009) Emotional reactions of Arab lay persons to a person with Alzheimer’s disease. Aging Ment Health 13(1):31–37CrossRef Cohen M, Werner P, Azaiza F (2009) Emotional reactions of Arab lay persons to a person with Alzheimer’s disease. Aging Ment Health 13(1):31–37CrossRef
16.
Zurück zum Zitat Meo SA, Hassan A, Usmani AM (2013) Research progress and prospects of Saudi Arabia in global medical sciences. Eur Rev Med Pharmacol Sci 17(24):3265–3271PubMed Meo SA, Hassan A, Usmani AM (2013) Research progress and prospects of Saudi Arabia in global medical sciences. Eur Rev Med Pharmacol Sci 17(24):3265–3271PubMed
18.
Zurück zum Zitat Cummings J, Lee G, Ritter A, Zhong K. Alzheimer’s disease drug development pipeline: 2018. Alzheimers Dement (N Y). 2018;4:195–214 Cummings J, Lee G, Ritter A, Zhong K. Alzheimer’s disease drug development pipeline: 2018. Alzheimers Dement (N Y). 2018;4:195–214
19.
Zurück zum Zitat Yuri jang, Kim G, Chiriboga D (2010) Knowledge of Alzheimer’s disease, feelings of shame, and awareness of services among Korean American elders. J Aging Health 22(4):419–433CrossRef Yuri jang, Kim G, Chiriboga D (2010) Knowledge of Alzheimer’s disease, feelings of shame, and awareness of services among Korean American elders. J Aging Health 22(4):419–433CrossRef
20.
Zurück zum Zitat Rodgers JJ, Kass JS (2018) Assessment of medical decision-making capacity in patients with dementia. Continuum (Minneapolis Minnesta) 24(3):920–925 (Behavioral Neurology And Psychiatry) Rodgers JJ, Kass JS (2018) Assessment of medical decision-making capacity in patients with dementia. Continuum (Minneapolis Minnesta) 24(3):920–925 (Behavioral Neurology And Psychiatry)
21.
Zurück zum Zitat Barnes LL, Schneider JA, Boyle PA, Bienias JL, Bennett DA (2006) Memory complaints are related to Alzheimer disease pathology in older persons. Neurology 67(9):1581–1585CrossRef Barnes LL, Schneider JA, Boyle PA, Bienias JL, Bennett DA (2006) Memory complaints are related to Alzheimer disease pathology in older persons. Neurology 67(9):1581–1585CrossRef
22.
Zurück zum Zitat Van der mussele S, Mariën P, Saerens J et al (2014) Behavioral syndromes in mild cognitive impairment and Alzheimer’s disease. J Alzheimers Dis 38(2):319–329CrossRef Van der mussele S, Mariën P, Saerens J et al (2014) Behavioral syndromes in mild cognitive impairment and Alzheimer’s disease. J Alzheimers Dis 38(2):319–329CrossRef
Metadaten
Titel
Perception and attitude of the general population towards Alzheimer’s disease in Jeddah, Saudi Arabia
verfasst von
Hussein Algahtani
Bader Shirah
Asim Alhazmi
Abid Alshareef
Mohammed Bajunaid
Ahmad Samman
Publikationsdatum
12.11.2018
Verlag
Springer International Publishing
Erschienen in
Acta Neurologica Belgica / Ausgabe 2/2020
Print ISSN: 0300-9009
Elektronische ISSN: 2240-2993
DOI
https://doi.org/10.1007/s13760-018-1040-7

Weitere Artikel der Ausgabe 2/2020

Acta Neurologica Belgica 2/2020 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.